Being recognized as a world-renowned organization, OMICS International takes pride to introduce the commencement of “14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics” from October 17-18, 2016 at Kuala Lumpur, Malaysia. Special interest and theme of this conference is: “A step towards translating novel therapies to control Diabetes”. The conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. OMICS International’s Diabetes Medicare 2016 conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.

OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosts over 700 leading-edge peer  reviewed Open Access Journals and has organized over 1000 Scientific Conferences all over the world. OMICS International journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50000 eminent personalities and the rapid, quality and quick review processing. OMICS International Conference is a great platform for the researchers to understand the need of new Antibiotics and the threat going to face by antibiotic resistance. Target Audience for Antibiotics 2016 includes Researchers, Industrialists, Students and Public Sector Experts.

OMICS International welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under single roof. Diabetes Medicare 2016 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetes Medicare 2016 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes Medicare 2016 is where the future of management and novel therapeutics for the disease intersects.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. In 2013, the value of the diabetes therapeutics market in Asia-Pacific (APAC) countries was an estimated $6.5 billion, and it is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7.1% between 2013 and 2020 to $10.5 billion. The latest report states that of the four major APAC countries (China, India, Japan and Australia), China will see the fastest expansion, with a CAGR of 11.1% over the forecast period. This will be driven by an increase in the prevalent population due to urbanization, advancement in the lifestyle of the people and by expected drug launches.

 

14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics is going to be held during October 17-18, 2016 at Kuala Lumpur, Malaysia. The special interest and theme of this conference is: “A step towards translating novel therapies to control Diabetes”. Diabetic Medications conference gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.

The conference throws light on thought provoking topics and recent research in the field of Diabetic Medications like, Type 1 Diabetes- Therapies and treatments, Type 2 Diabetes- Therapies and treatments, Diabetic Neuropathy-Treatment and Care, Management of Diabetic Heart Diseases, Management of Diabetic Kidney Diseases, Clinical Diabetic Therapeutics & Management, Islet Biology and Beta cell targeting, Computational Approaches for Diabetes, and many more. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Diabetes Medicare 2016 International Conference, where you are sure to have a meaningful experience with scholars from around the world. All the Organizing Committee Members of the Diabetes Medicare 2016 International Conference look forward to meet you in Las Vegas, Nevada, USA.

OMICS International welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conference, where all the aspects of diabetes will be discussed under single roof. Diabetes Medicare 2016 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetes Medicare 2016 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributing to the dissemination of knowledge in management of the disease for the benefit of the society. Diabetes Medicare 2016 is where the future of management and novel therapeutics for the disease intersects

For more details please visit- http://diabeticmedications.conferenceseries.com/

Importance & Scope

Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. According to WHO Diabetes was estimated to affect 371 million people till the end of 2011in US. Whereas, new figures indicate that the number of people living with diabetes is expected to rise from 371 million in 2012 to 552 million by 2030. This indicates an urgent alarm for its management. As the number of patients grows across the globe, there has never been a stronger and more urgent need for therapeutic measures that arrest the growth of the disease and alleviate its secondary manifestations. In Type 1 diabetes total β-cell loss occurs. In Type 2 diabetes, partial β-cell loss occurs before diagnosis, and the progressive β-cell loss during the life of the patient increases the severity of the disease. This addresses novel therapies for these deficiencies in clinical and preclinical evaluation.

Many International Conferences and Diabetic therapies meetings/ symposium and workshops have been organized on different topics related to the risk factors related to diabetes across the globe such as glucose tolerability conference, diabetes stem cell cure conference, anti-diabetic agents meetings, obesity conferences, weight loss conferences, Islet transplantation international conference, glucose variability conferences etc. Besides that many international events such as diabetes alternative medicines events, insulin pump therapy events, pancreatic dysfunction events, recombinant approaches for diabetes events etc. Targeted Therapy Events have been also taking place in order to find a weapon against fatal diseases like diabetic foot, insulin resistance, glucose tolerability, obesity and to discuss the role of diabetes in cardiovascular diseases, kidney diseases, risk of cancer and intolerability to cure the wound which will gives a better insight about the associated causes and disease portfolio.

Why Malaysia (Asia-Pacific)?

It is our great pleasure to welcome you to International Conference on Targeting Diabetes and Novel Therapeutics to be held in Kuala Lumpur, Malaysia. The Diabetic Medications-2016 meeting offers a unique opportunity to gather and network with colleagues from around the world in an exciting educational and professional environment in the field of diabetes.

Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. In 2013, the value of the diabetes therapeutics market in Asia-Pacific (APAC) countries was an estimated $6.5 billion, and it is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7.1% between 2013 and 2020 to $10.5 billion. The latest report states that of the four major APAC countries (China, India, Japan and Australia), China will see the fastest expansion, with a CAGR of 11.1% over the forecast period. This will be driven by an increase in the prevalent population due to urbanization, advancement in the lifestyle of the people and by expected drug launches.

Hospitals Associated with Diabetes Research

Diabetes being one of the most fatal, most fast-growing diseases in the world with the maximum elevation rate in the incidence has best hospitals across the globe. Diabetes has maximum sufferings in China, USA and in the Asia pacific region giving a reason to have best management. Best Endocrinology hospitals as per the area are as follows:

Best Diabetes hospitals in USA:

Over 29.1 million people (9.3 percent) of the U.S. population currently has diabetes, reports the Centers for Disease Control, and it is an epidemic that seems to be growing. Not only is diabetes detrimental to one’s health, but it is also a costly disease to treat. The total estimated cost of diagnosed diabetes in 2012 was $245 billion, according to the ADA, including $176 billion in direct medical costs and $69 billion in reduced productivity.

1. Mayo Clinic (Rochester, MN)
2. Cleveland Clinic (Cleveland, OH)
3. Massachusetts General Hospital (Boston, MA)
4. Johns Hopkins Hospital (Baltimore, MD)
5. UCSF Medical Center (San Francisco, CA)
6. New York-Presbyterian University Hospital of Weill Cornell (New York, NY)
7. Yale-New Haven Hospital (New Haven, CT)
8. Northwestern Memorial Hospital (Chicago, IL)
9. UCLA Medical Center (Los Angeles, CA)
10. University of Washington Medical Center (Seattle, WA)

Best Diabetes hospitals in Asia:

1. Buddhist Tzu Chi General Hospital
2. Taipei Veterans General Hospital
3. Xinqiao Hospital Third Military Medical University
4. National Taiwan University Hospital
5. Jilin University Bethune Hospital - First Hospital of Jilin University
6. Hospital Authority
7. National Hospital Organization
8. Peking Union Medical College Hospital Beijing
9. Beijing Hospital
10. King Faisal Specialist Hospital & Research Centre

The high prevalence of the disease requires the best management and prevention obscuring the best hospitals around the world, especially in the highly prevalent areas.

 

Associations Associated with Diabetes Research

To encourage, educate, update and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well-known societies/associations are working across the globe to efficiently prevent and combat the fatal disease.

Major Diabetes Associations around the Globe

1. Diabetes Indian Association
2. Canadian Diabetes Association
3. International Diabetes Federation
4. Diabetes Australia
5. Austrian Diabetes Association
6. Diabetes UK
7. Diabetes South Africa
8. Spanish Diabetes Society (Spain)
9. Swedish Diabetes Association
10. Korean Diabetes Association

Major Diabetes Associations in Asia

1. The Japan Diabetes Society
2. Asian Association for Study of Diabetes (AASD)
3. The Diabetic Society of Singapore
4. Afghanistan Diabetes Association
5. Azerbaijan Diabetes Society
6. Bahrain Diabetes Society
7. Chinese Diabetes Society
8. Jordanian Society for the Care of Diabetes
9. Korean Diabetes Association
10. Persatuan Diabetis Malaysia

Major Diabetes Associations in Malaysia:

1. Malaysian Endocrine & Metabolic Society
2. The Asian Association for the Study of Diabetes
3. Malaysian Diabetes Association
4. Malaysian Diabetes Educators Society
5. Persatuan Diabetes Malaysia

 

Universities Associated with Diabetes Research

There are around 5000 medical universities in the world out of which approximately 3000 universities focusing on Endocrinology and Diabetes researches.

Top Medical Universities for Diabetes in the world:

1. Albany Medical College
2. Baylor College of Medicine
3. Creighton University School of Medicine
4. Dartmouth Medical School
5. Florida International University College of Medicine
6. Georgetown University School of Medicine
7. Howard University College of Medicine
8. Harvard Medical School
9. Johns Hopkins University School of Medicine
10. Pennsylvania State University College of Medicine

Top Medical Universities of Endocrinology in Asia:

1. University of Tokyo
2. National University of Singapore (NUS)
3. Kyoto University
4. University of Hong Kong (HKU)
5. Peking University
6. Seoul National University (SNU)
7. National Taiwan University (NTU)
8. Osaka University
9. The Chinese University of Hong Kong (CUHK)
10. Tsinghua University

Top Medical Universities of Endocrinology in Malaysia:

1. International Medical University (IMU)
2. Sunway University
3. Monash University Malaysia
4. Universiti Sains Malaysia (USM)
5. Help University College
6. University of Malaya Medical Center & Faculty of Medicine
7. University of Malaya (Institute of Graduate Studies)
8. Universiti Putra Malaysia (UPM)
9. UCSI University
10. Nilai University

 

Companies Associated with Diabetic products and their funding

 

Glance at Market of Diabetes

Global Market for Diabetes Therapies & Diagnostics is to be worth $51.2 billion in 2015. The diabetes market, consisting mainly of Type 1 and Type 2 diabetes, is large and growing significantly.

According to a new technical market research report, 'Diabetes Therapies and Diagnostics' from BCC Research, the global market value for diabetes therapies and diagnostics is an estimated $38 billion in 2010, but is expected to increase to $51.2 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 6.1 per cent. The largest segment of the market, insulin products (including administration devices), is estimated to be worth $16.4 billion in 2010, and is expected to increase at a CAGR of 6.1 per cent to reach $22 billion in 2015.

Monitoring devices and accessories, the second-largest segment, is expected to reach $14.1 billion in 2015, after increasing from the 2010 estimate of $11.3 billion at a CAGR of 4.5 per cent. The fastest-growing segment, oral hypoglycemic drugs, is projected to increase at a CAGR of 8 per cent, increasing from an estimated $10.3 billion in 2010 to $15.1 billion in 2015.

Projections: Growth by next 5-10 years

According to a new technical market research report, 'Diabetes Therapies and Diagnostics' from BCC Research, the global market value for diabetes therapies and diagnostics is an estimated $38 billion in 2010, but is expected to increase to $51.2 billion in 2015, for a 5-year compound annual growth rate (CAGR) of 6.1 percent.